69% have been using the medication for fewer than two years and 53% expect to discontinue use in less than two more years 77% who had discontinued a GLP-1 medication said they were satisfied with the weight loss they experienced, but 90% were on the drug for less than one year Primary barriers to continued use: 76% note side effects
Where is my order
Foundayo can still be the right choice for the right patient, especially those with strong needle aversion, milder weight categories, or demanding travel schedules
Some of the GLP-1s approved to treat T2D, such as Ozempic, are also widely known to be used for weight loss
Why the Injection Site Matters You might wonder, If the medicine is going under my skin, why cant I just pick any spot? Here are three big reasons site choiceand rotationreally counts: 1
If youre ready to find out whether you qualify and which medication fits your situation, take the intake assessment to get started with a provider